~~<i id='704144ED1A'><strike id='704144ED1A'><tt id='704144ED1A'><pre id='704144ED1A'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：entertainment 2025-09-30 04:10:10 Page View：1941

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： NIH launches clinical trials and new research office for long Covid
Next article： The high cost of giving birth even with insurance

knowledge

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Adults seen as increasingly susceptible to measles

MikeReddyforSTATSimonMatthewsmadethreetripsthisspringtotheemergencyroomofhislocalhospitalinEastbourn

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Lawsuit alleges UnitedHealth Group unit illegally denied claims

JimMone/APTheU.S.DepartmentofLaborclaimsinanewlawsuitthataUnitedHealthGroupunitillegallyrejectedemer

WSS

hotspot

hotspot

explore

knowledge

Lawsuit alleges UnitedHealth Group unit illegally denied claims